Sarepta Therapeutics Reports Third-Quarter 2026 Financial Results
Sarepta reported its third-quarter 2026 financial results. The supplied body is truncated and provides no figures.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter of 2026.“After my first 90 days at Sarepta, I believe the fundamental strengths that attracted me to the company remain firmly intact: a durab…